Literature DB >> 9027517

Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49.

S W Duffy1, H H Chen, L Tabar, G Fagerberg, E Paci.   

Abstract

BACKGROUND: In mammographic screening for breast cancer in women aged 40-49, previous studies have found very low estimates of sensitivity and predictive value. Methods of estimation have, however, used primitive models with relatively strong assumptions and less than full use of the data.
METHODS: Here we estimate the underlying preclinical incidence, mean sojourn time, sensitivity and positive predictive value by a variety of methods in a randomized trial of mammographic screening (The Swedish Two-County Trial) and a service screening programme (The Florence Programme, 1975-1986) in women aged 40-49 years.
RESULTS: In the Two-County study, sensitivity estimates ranged from 72-83% and predictive value from 39-89%. In the Florence programme, sensitivity estimates ranged from 69-85% and predictive value was uniformly estimated as 100%.
CONCLUSIONS: The methods involving more explicit modelling of the disease process and fewer assumptions tended to find higher estimates of predictive value in the Two-County study. The results suggest that previously poor sensitivity and predictive value estimates may have been overpessimistic.

Entities:  

Mesh:

Year:  1996        PMID: 9027517     DOI: 10.1093/ije/25.6.1139

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  12 in total

1.  Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

Authors:  D M Eccles; D G Evans; J Mackay
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

2.  A reality check for overdiagnosis estimates associated with breast cancer screening.

Authors:  Ruth Etzioni; Jing Xia; Rebecca Hubbard; Noel S Weiss; Roman Gulati
Journal:  J Natl Cancer Inst       Date:  2014-10-31       Impact factor: 13.506

Review 3.  DCIS, cytokeratins, and the theory of the sick lobe.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2005-05-31       Impact factor: 4.064

4.  Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.

Authors:  Yinlu Chen; Guy Brock; Dongfeng Wu
Journal:  Cancer Epidemiol       Date:  2010-08       Impact factor: 2.984

5.  Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.

Authors:  Ayush Sharma; Thomas C Smyrk; Michael J Levy; Mark A Topazian; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-04-30       Impact factor: 22.682

6.  Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures.

Authors:  S Moss; M Waller; T J Anderson; H Cuckle
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

7.  Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study.

Authors:  S Taghipour; D Banjevic; A B Miller; N Montgomery; A K S Jardine; B J Harvey
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

8.  Inferences for the Lead Time in Breast Cancer Screening Trials under a Stable Disease Model.

Authors:  Justin Shows; Dongfeng Wu
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

Review 9.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

10.  Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.

Authors:  J McCann; S Duffy; N Day
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.